Suppression of Enhancer Overactivation by a RACK7-Histone Demethylase Complex

Shen, Hongjie, Xu, Wenqi, Guo, Rui, Rong, Bowen, Gu, Lei, Wang, Zhentian, He, Chenxi, Zheng, Lijuan +8 more·2016·Cell
DOI 10.1016/j.cell.2016.02.064

Cited by (186)

Items 101–186 of 186

  1. Super-Enhancers and Their Parts: From Prediction Efforts to Pathognomonic Status
    Anastasia V. Vasileva, Marina G. Gladkova, German A. Ashniev, Ekaterina D. Osintseva, А. В. Орлов, Ekaterina V. Kravchuk, Anna Boldyreva, Alexandr G. Burenin, Petr Ivanovich Nikitin, Natalia N. Orlova · 2024 · International Journal of Molecular Sciences
  2. Biology and targeting of the Jumonji-domain histone demethylase family in childhood neoplasia: a preclinical overview
    Tyler S. McCann, Lays Martin Sobral, Chelsea Self, Joseph Chia Yu Hsieh, Marybeth Sechler, Paul Jedlicka · 2019 · Expert Opinion on Therapeutic Targets
  3. ZMYND8 promotes the growth and metastasis of hepatocellular carcinoma by promoting HK2-mediated glycolysis
    Changwei Dou, Huanye Mo, Tianxiang Chen, Jie Liu, Yuqun Zeng, Shuangshuang Li, Cheng Guo, Chengwu Zhang · 2021 · Pathology - Research and Practice
  4. Dual histone reader ZMYND8 inhibits cancer cell invasion by positively regulating epithelial genes
    Moitri Basu, Isha Sengupta, Md. Wasim Khan, Dushyant Kumar Srivastava, Partha Chakrabarti, Siddhartha Roy, Chandrima Das · 2017 · Biochemical Journal
  5. Dismissal of RNA Polymerase II Underlies a Large Ligand-induced Enhancer Decommissioning Program
    Yuliang Tan, Chun-Yu Jin, Wubin Ma, Yi-ren Hu, B. Tanasa, Soohwan Oh, A. Gamliel, Qi Ma, Lu Yao, Jie Zhang et al. · 2018 · Molecules and Cells
  6. Highly Selective 5-Formyluracil Labeling and Genome-wide Mapping Using (2-Benzimidazolyl)Acetonitrile Probe
    Yafen Wang, Chaoxing Liu, Fan Wu, Xiong Zhang, Sheng Liu, Zonggui Chen, Weiwu Zeng, Wei Yang, Xiao‐Lian Zhang, Yu Zhou et al. · 2018 · iScience
  7. Regulation of KDM5C stability and enhancer reprogramming in breast cancer
    Qiong Xiao, Chenyu Wang, Chuan Gao, Jidong Chen, Jingjing Chen, Zhen Wang, Lingao Ju, Shan‐Bo Tang, Jie Yao, Li Feng et al. · 2022 · Cell Death and Disease
  8. The Structure of the ZMYND8/Drebrin Complex Suggests a Cytoplasmic Sequestering Mechanism of ZMYND8 by Drebrin
    Ningning Yao, Jianchao Li, Haiyang Liu, Jun Wan, Wei Liu, Mingjie Zhang · 2017 · Structure
  9. Targeting the histone reader ZMYND8 inhibits antiandrogen-induced neuroendocrine tumor transdifferentiation of prostate cancer
    Hanling Wang, Sulin Zhang, Qiang Pan‐Hammarström, Jiacheng Guo, Li Ni, Lifan Chen, Jun‐Yu Xu, Jingyi Zhou, Yongqiang Gu, Xuege Wang et al. · 2025 · Nature Cancer
  10. Activation, decommissioning, and dememorization: enhancers in a life cycle
    Xiaotong Wu, Xi Wu, Wei Xie · 2023 · Trends in Biochemical Sciences
  11. ZMYND8 expression combined with pN and pM classification as a novel prognostic prediction model for colorectal cancer: Based on TCGA and GEO database analysis
    Jiewei Chen, Qing‐Mei He, Peishan Wu, Jianchang Fu, Yongbo Xiao, Keming Chen, Dan Xie, Xinke Zhang · 2020 · Cancer Biomarkers
  12. microRNA-181a promotes the oncogene S100A2 and enhances papillary thyroid carcinoma growth by mediating the expression of histone demethylase KDM5C
    Yahui Wang, H Ye, Yuan Yang, Jiaying Li, Aiying Cen, Lei Zhao · 2021 · Journal of Endocrinological Investigation
  13. Autism-associated protein POGZ controls ESCs and ESC neural induction by association with esBAF
    Xiaoyun Sun, Linxi Cheng, Yuhua Sun · 2022 · Molecular Autism
  14. Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer
    Xiang Lin, Jidong Chen, Chen-Yu Wang, Zhen Cai, Rui Zhan, Yang Chen, La-Ying Zhang, Lianyun Li, Yong Xiao, Mingkai Chen et al. · 2023 · Genome biology
  15. Super-enhancers in tumors: unraveling recent advances in their role in Oncogenesis and the emergence of targeted therapies
    Yu‐meng Ji, Baixue Li, Rongjin Lin, Jing Tang Yuan, Yang Han, Yuping Du, Yang Zhao · 2025 · Journal of Translational Medicine
  16. Genome-Wide Enhancer Analysis Reveals the Role of AP-1 Transcription Factor in Head and Neck Squamous Cell Carcinoma
    Chen-Yu Wang, Guang‐Tao Yu, Chuan Gao, Ji Chen, Qinglan Li, Lu Zhang, Min Wu, Zhi‐Jun Sun, Lianyun Li · 2021 · Frontiers in Molecular Biosciences
  17. Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote Radioresistance
    Stephen V. Carney, Kaushik Banerjee, Anzar Mujeeb, Brandon J. Zhu, Santiago Haase, Maria Luisa Varela, Padma Kadiyala, Claire E. Tronrud, Ziwen Zhu, Devarshi Mukherji et al. · 2023 · Clinical Cancer Research
  18. H3K4me3 amplifies transcription at intergenic active regulatory elements
    Haoming Yu, Yongyan Zhang, Zhicong Liao, Benjamin William Walters, Bluma J. Lesch · 2025 · Genes & Development
  19. Chromatin Sensing by the Auxiliary Domains of KDM5C Regulates Its Demethylase Activity and Is Disrupted by X-linked Intellectual Disability Mutations
    Fatima S. Ugur, Mark J. S. Kelly, Danica Galonić Fujimori · 2022 · Journal of Molecular Biology
  20. Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer
    Sumin Oh, Je Yeong Ko, Chaeun Oh, Kyung Hyun Yoo · 2017 · Advances in experimental medicine and biology
  21. Membrane-bound transcription factor LRRC4 inhibits glioblastoma cell motility
    Yang Liu, Gang Xu, Haijuan Fu, Peiyao Li, Danyang Li, Kun Deng, Wei Gao, Yujie Shang, Minghua Wu · 2023 · International Journal of Biological Macromolecules
  22. Catalytic-independent functions of the Integrator–PP2A complex (INTAC) confer sensitivity to BET inhibition
    Pengyu Fan, Xue-Ying Shang, Aixia Song, Shuo Chen, Run-Yuan Mao, Jingchuan Ma, Jiwei Chen, Zhenning Wang, Hai Zheng, Bolin Tao et al. · 2025 · Nature Chemical Biology
  23. ZMYND8 suppresses MAPT213 LncRNA transcription to promote neuronal differentiation
    Santanu Adhikary, Vipin Singh, Ramesh Choudhari, Barbara Carolyn Yang, Swagata Adhikari, Enrique Ramos, Soumi Chaudhuri, Siddhartha Roy, Shrikanth S. Gadad, Chandrima Das · 2022 · Cell Death and Disease
  24. ZMYND8 promotes the Warburg effect and tumorigenesis through c-Myc activation in pancreatic cancer
    Hui Liu, Zhifeng Zhao, Changle Wu, Jinxin Chen, Zhiwei He, Kai Jiang · 2025 · Oncogene
  25. A novel role of tumor suppressor ZMYND8 in inducing differentiation of breast cancer cells through its dual-histone binding function
    Shravanti Mukherjee, Sabyasachi Sen, Santanu Adhikary, Amrita Sengupta, Pratiti Mandal, Dipak Dasgupta, Partha Chakrabarti, Siddhartha Roy, Chandrima Das · 2020 · Journal of Biosciences
  26. Zinc finger myeloid Nervy DEAF-1 type (ZMYND) domain containing proteins exert molecular interactions to implicate in carcinogenesis
    Longji Wu, Jing Li Huang, Pankaj Trivedi, Xuerong Sun, Hongbing Yu, Zhiwei He, Xiangning Zhang · 2022 · Discover Oncology
  27. Elevated histone demethylase KDM5C increases recurrent miscarriage risk by preventing trophoblast proliferation and invasion
    Min Xiao, Yan Zheng, Meng‐Xi Wang, Yi-Hua Sun, Juan Chen, Kang-Yong Zhu, Fan Zhang, Yunhui Tang, Fan Yang, Ting Zhou et al. · 2022 · Cell Death Discovery
  28. Protein kinase C binding protein 1 inhibits hypoxia-inducible factor-1 in the heart
    Kathryn Jaques Schunke, Chad B. Walton, David Veal, Chrisy Mafnas, Cynthia D. Anderson, Allison Lesher Williams, Ralph V. Shohet · 2018 · Cardiovascular Research
  29. HBO1 functions as an epigenetic barrier to hepatocyte plasticity and reprogramming during liver injury
    Yuan, Wei-Chien, Earl, Andrew S., Ma, Sai, Alcedo, Karel, Russell, Jacquelyn O., Duarte, Fabiana M., Chu, Yen-Ting, Chang, Pei-Chi, Chen, Hsin-Yi, Chi, Hsin-Hui et al. · 2025 · Cell Stem Cell
  30. KDM5C-Mediated Recruitment of BRD4 to Chromatin Regulates Enhancer Activation and BET Inhibitor Sensitivity
    Yulong Qiang, Jiachen Fan, Chuanshuai Xie, Leilei Yan, Xiaofei Song, Nan Zhang, Yan Lin, Jie Xiong, Wei Zhang, Yu Liu et al. · 2024 · Cancer Research
  31. Interrogation of the interplay between DNA N6-methyladenosine (6mA) and hypoxia-induced chromatin accessibility by a randomized empirical model (EnrichShuf)
    Joseph Chieh‐Yu Lai, Kai‐Wen Hsu, Kou‐Juey Wu · 2024 · Nucleic Acids Research
  32. Low expression of ZMYND8 correlates with aggressive features and poor prognosis in nasopharyngeal carcinoma
    Jiewei Chen, Jun Liu, Xiaoting Chen, Yong Li, Zizi Li, Chengchao Shen, Keming Chen, Xinke Zhang · 2019 · Cancer Management and Research
  33. Beyond FOXO1: AS1842856 inhibits GSK3 to enhance cytotoxic effects in B-ALL
    Franz Ketzer, Ulrike F. G. Büttner, Daniel Geist, Anita B. Kick, Thomas Wirth, Alexey Ushmorov · 2025 · Blood Advances
  34. A BACH1 inhibitor ameliorates myocardial infarction and limb ischemia in mice
    Jiayi Lin, Xin Liu, Qinhan Li, Fei Ge, Jinghua Ma, Xianlong NG, Qi Pan, Xiangxiang Wei, Qingjun Jiang, Jiayu Jin et al. · 2025 · Molecular Therapy
  35. Integrative RNA-Seq and H3 Trimethylation ChIP-Seq Analysis of Human Lung Cancer Cells Isolated by Laser-Microdissection
    Quang Ong, Shingo Sakashita, Emi Hanawa, Naomi Kaneko, Masayuki Noguchi, Masafumi Muratani · 2021 · Cancers
  36. Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma
    Sangjoon Choi, Keun‐Woo Lee, Hyun Hee Koh, Sujin Park, So-Young Yeo, Jae‐Won Joh, Moon Seok Choi, Seok‐Hyung Kim, Cheol-Keun Park, Sang Yun Ha · 2021 · Journal of Cancer Research and Clinical Oncology
  37. Multifaceted regulation of enhancers in cancer
    Qiong Xiao, Yong Xiao, Lianyun Li, Mingkai Chen, Min Wu · 2022 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  38. LSD1/KDM1A Maintains Genome-wide Homeostasis of Transcriptional Enhancers
    Saurabh Agarwal, Patricia Marie Garay, Robert S. Porter, Emily Brookes, Yumie Murata-Nakamura, Todd S. Macfarlan, Bing Ren, Shigeki Iwase · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  39. Retraction Note: TET2 inhibits tumorigenesis of breast cancer cells by regulating caspase-4
    Xuguo Zhu, Shuangqi Li · 2019 · Scientific Reports · Retracted
  40. The RBM39 degrader indisulam inhibits acute megakaryoblastic leukemia by altering the alternative splicing of ZMYND8
    Ying Hua Yang, Zhiheng Li, Yang Yang, Peifang Xiao, Zhixu He, Zimu Zhang, Yizhen Li, Lei Shi, Xiaodong Wang, Yanfang Tao et al. · 2025 · Cell & Bioscience
  41. The Integrator–PP2A complex integrates promoter-proximal premature termination with chromatin context and genome maintenance
    Aixia Song, Danyi Lu, Fei Chen · 2025 · Trends in Biochemical Sciences
  42. BRAIN-MAGNET: A functional genomics atlas for interpretation of non-coding variants
    Ruizhi Deng, Elena Perenthaler, Anita Nikoncuk, Soheil Yousefi, Kristina Lanko, Rachel Schot, Michela Maresca, Eva Medico Salsench, Leslie E. Sanderson, Michael J. Parker et al. · 2025 · Cell
  43. KDM5C is a sex-biased brake against germline gene expression programs in somatic lineages
    Katherine M. Bonefas, Ilakkiya Venkatachalam, Shigeki Iwase · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  44. Epigenetic Landscape and Therapeutic Implication of Gene Isoforms of Doublecortin-Like Kinase 1 for Cancer Stem Cells
    Landon L. Moore, Courtney W. Houchen · 2023 · International Journal of Molecular Sciences
  45. Targeting the transcription factor YY1 is synthetic lethal with loss of the histone demethylase KDM5C
    Qian Zheng, Pengfei Li, Yulong Qiang, Jiachen Fan, Yuzhu Xing, Ying Zhang, Fan Yang, Feng Li, Jie Xiong · 2024 · EMBO Reports
  46. Histone Readers and Their Roles in Cancer
    Hong Wen, Xiaobing Shi · 2023 · Cancer treatment and research
  47. Genomic Frequencies of Dynamic DNA Sequences and Mammalian Lifespan
    Marianna Martella, Nadia Carlesso, Zoë A. E. Waller, Guido Marcucci, Flavia Pichiorri, Steven S. Smith · 2024 · Cancer Genomics & Proteomics
  48. Chromatin and Epigenetics at the Forefront: Finding Clues among Peaks
    Sergi Aranda, Yang Shi, L. Di Croce · 2016 · Molecular and Cellular Biology
  49. Structural Basis of RACK7 PHD Domain to Read a Pediatric Glioblastoma‐Associated Histone Mutation H3 . 3G34R
    Wenxian Lan, Ze Li, Fangfang Jiao, Chunxi Wang, Rui Guo, Chunyang Cao · 2021 · Chinese Journal of Chemistry
  50. Histone lysine demethylases in breast cancer: molecular mechanisms, biological functions, and therapeutic intervention
    Anqi Wang, Dianjun Qi, Y. Ma, Mozhi Wang, Haoran Dong, Chenxin Wang, Yingfan Zhang, Zheyuan Zhang, Lingwei Li, J H Xu et al. · 2025 · Molecular Cancer
  51. Bioinformatics Analysis Reveals the Oncogenic Role and Therapeutic Potential of lncRNA SNHG25 in Colon Adenocarcinoma
    Renshan Hao, Ye Zhang, Qi Zhu, Pufang Tan · 2025 · International Journal of Genomics
  52. BACH1 recruits STAT3 to enhance leukemia inhibitory factor receptor activity and augments the self-renewal capacity of mouse embryonic stem cells
    Jinghua Ma, Siyu Ma, Cong Niu, Siqing Wang, Xiangxiang Wei, Dan Meng, Xiuling Zhi, Jieyu Guo · 2025 · Stem Cell Research & Therapy
  53. Pathophysiological significance of impaired KAT7-dependent histone H3K14 acetylation during zinc deficiency
    Takao Fujisawa, Satoshi Takenaka, Lila Maekawa, Motoyuki Ogawa, Toshiyuki Kowada, Toshitaka Matsui, Shin Mizukami, Yugo Kato, Michio Suzuki, Hisashi Noma et al. · 2026 · Nature Communications
  54. Cancer research driven by cutting-edge multi-disciplinary technologies
    Qunyan Lyu, Yukuan Feng, Rong Shi, Jing Wu, Weidong Han · 2020 · Chinese Science Bulletin (Chinese Version)
  55. Catalytic-independent functions of INTAC in conferring sensitivity to BET inhibition
    Pengyu Fan, Xue-Ying Shang, Aixia Song, Shuo Chen, Run-Yuan Mao, Jiwei Chen, Zhenning Wang, Hai Zheng, Bolin Tao, Wei Xu et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  56. RACK7 Interacts with PRC2 Complex to Regulate Astrocyte Development
    Fangfang Jiao, Tianxiang Tang, Bowen Wang, Shengfei He, Yue Zhang, Li Dong, Bo Xu, Ying Liu, Ping Zhu, Rui Guo · 2025 · Advanced Science
  57. RACK7 senses and fine-tunes enhancer activity
    Li Dong, Daixuan Zhang, Ying Cai, Min Zeng, Mandi Mu, Peng Fei Zhao, Jin Wang, Siyi Cheng, Qingqing Cai, Jian Zhang et al. · 2025 · iScience
  58. Intrinsically Disordered Regions of Zinc Finger Protein 687 in Phase Separation: A Potentially Pathogenic Driver of Paget’s Disease of Bone
    Jing Wang, Zheng Guo, Muqing Zhang, Hu Wang · 2025 · ACS Pharmacology & Translational Science
  59. Cooperative control of neuron-specific repressive chromatin states by intellectual-disability-linked KDM1A and KDM5C demethylases
    Ana Martín-González, Juan Paraíso‐Luna, Sergio Niñerola, Beatriz del Blanco, Rita M Robles, Macarena Lorena Herrera, Rafael Muñoz‐Viana, Emilio Geijo‐Barrientos, Ángel Barco · 2025 · Cell Reports
  60. KDM5B cooperates with CRL4B complex to promote the tumorigenesis of ER+ breast cancer via regulating cholesterol metabolism
    Yunkai Yang, Tianyang Gao, Baowen Yuan, Xinhui Hao, Miaomiao Huo, Ting Hu, Tianyu Ma, Min Zhang, Die Zhang, Xu Teng et al. · 2026 · Cell Death and Disease
  61. KDM5C-regulated SIX5 promotes glioblastoma progression through transcriptional activation of UBE2C and enhancement of the Warburg effect
    Zhang Li, Nan Wang, Defeng Liu, Yunshan Wang, Haiying Li · 2026 · Frontiers in Immunology
  62. SIRT6 cooperates with KDM5C to transcriptionally silence MICAL2 and inhibit tumorigenesis in pancreatic cancer
    Shuai Leng, Wenyan Liu, Yu Han, Zhiqiao Dang, Fengquan Zhang, Wenqian Yu · 2026 · Cell Communication and Signaling
  63. KDM5 Lysine Demethylases in Pathogenesis, from Basic Science Discovery to the Clinic
    Shang‐Min Zhang, Jian Ping Cao, Qin Yan · 2023 · Advances in experimental medicine and biology
  64. NamiRNA-mediated high expression of KNSTRN correlates with poor prognosis and immune infiltration in hepatocellular carcinoma
    Liang Jin, Xiaojing Zhang, Ming Fan, Weimin Li, Xuan Zhang · 2023 · Współczesna Onkologia
  65. NamiRNA-mediated high expression of KNSTRN correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma
    Liang Jin, Xiaojing Zhang, Ming Fan, Weimin Li, Quanyou Lai, Wei Peng, Xuan Zhang · 2023 · Research Square
  66. H3K4me3 instructs transcription at intergenic active regulatory elements
    Haoming Yu, Yongyan Zhang, Zhicong Liao, Benjamin William Walters, Bluma J. Lesch · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  67. The Role of RNF40 mediated H2B monoubiquitination in transcription
    Wanhua Xie · 2017
  68. The ZMYND8 chromatin factor protects cardiomyocyte identity and function in the mouse heart
    Andrew Kekūpaʻa Knutson, Abigail Avelar, Ralph V. Shohet · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  69. Comparative evaluation of ZMYND-8 and RARβ2 genes promoters’ methylation changes in tumor and tumor margin tissues of patients with lung cancer
    Mahdieh Pourasghariazar, Habib Zarredar, Milad Asadi, Ayşe Caner, Aisan Akhgari, Hamed Valizadeh, Soghra Bornehdeli, Shahryar Hashemzadeh, Mortaza Raeisi · 2023 · Egyptian Journal of Medical Human Genetics
  70. Data from ZMYND8 Expression in Breast Cancer Cells Blocks T-Lymphocyte Surveillance to Promote Tumor Growth
    Yong Wang, Maowu Luo, Yan Chen, Yijie Wang, Bo Zhang, Zhenhua Ren, Lei Bao, Yanan Wang, Jennifer E. Wang, Yang‐Xin Fu et al. · 2023
  71. Additional file 1 of Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer
    Lin, Xiang, Chen, Ji-Dong, Wang, Chen-Yu, Cai, Zhen, Zhan, Rui, Yang, Chen, Zhang, La-Ying, Li, Lian-Yun, Xiao, Yong, Chen, Ming-Kai et al. · 2023 · Figshare
  72. Additional file 3 of Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer
    Lin, Xiang, Chen, Ji-Dong, Wang, Chen-Yu, Cai, Zhen, Zhan, Rui, Yang, Chen, Zhang, La-Ying, Li, Lian-Yun, Xiao, Yong, Chen, Ming-Kai et al. · 2024 · Figshare
  73. Additional file 1 of Autism-associated protein POGZ controls ESCs and ESC neural induction by association with esBAF
    Sun, Xiaoyun, Linxi Cheng, Yuhua Sun · 2022 · Figshare
  74. Additional file 4 of Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer
    Lin, Xiang, Chen, Ji-Dong, Wang, Chen-Yu, Cai, Zhen, Zhan, Rui, Yang, Chen, Zhang, La-Ying, Li, Lian-Yun, Xiao, Yong, Chen, Ming-Kai et al. · 2024 · Figshare
  75. Additional file 2 of Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer
    Lin, Xiang, Chen, Ji-Dong, Wang, Chen-Yu, Cai, Zhen, Zhan, Rui, Yang, Chen, Zhang, La-Ying, Li, Lian-Yun, Xiao, Yong, Chen, Ming-Kai et al. · 2024 · Figshare
  76. Additional file 5 of Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer
    Lin, Xiang, Chen, Ji-Dong, Wang, Chen-Yu, Cai, Zhen, Zhan, Rui, Yang, Chen, Zhang, La-Ying, Li, Lian-Yun, Xiao, Yong, Chen, Ming-Kai et al. · 2024 · Figshare
  77. ERRα-KDM5C restrains STING enhancer activity to modulate type I interferon signaling in breast cancer progression
    Zu-Hui Xu, Jie Chen, Ying He, Cheng Lei, Xiao-Ling Wang, Defa Huang, Zheng-Zhe Li, Hui Zhou, Mei-Yan Wang, Cheng-Gui Song et al. · 2026 · Cell Death and Disease
  78. Noncanonical role of KDM5C in conferring bortezomib resistance via the PERK‒Nrf2 axis in multiple myeloma
    Peifen Lu, Wenbin Shangguan, Weiwei Qian, Dongliang Wu, Wenyang Li, Jingjing Huang, Peipei Xu, Dijun Chen, Feng Li, Bing Chen et al. · 2026 · Cell Death and Disease
  79. Décryptage de dynamiques épigénomiques au cours de la thymopoïèse et de la spermatogenèse en appliquant une méthodologie de recherche reproductible à des données de séquençage à haut débit
    Guillaume Charbonnier · 2019 · theses.fr (ABES)
  80. L’hétérochromatine duale H3K9me3/H3K36me3 dépendante de SETDB1 et des NSDs assure l’expression des gènes en maintenant les enhancers inactifs
    Amandine Barral · 2021 · theses.fr (ABES)
  81. H3K4me3 exhibits length-dependent deposition patterns at transcription initiation regions in Trypanosoma cruzi and correlates with transcriptional activity
    María del Rosario López, Iván Federico Berco Gitman, Alejo Facundo Prego, Rosario Lavignolle, Romina Trinidad Zambrano Siri, Santiago Carena, Rafael José Argüello, Salomé Catalina Vilchez Larrea, G. Alonso, Josefina Ocampo · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  82. Dual Role of Tamoxifen in Enhancing STING and CEACAM1 Expression to Prime a Favorable Tumor Microenvironment for Anti‐TIM3 Immunotherapy
    Marvin Angelo Esteban Aberin, Saurabh Singh, Soumya Chatterjee, Guang‐Zhi Sui, Yi-Fu Wang, Ya-Ting Lu, Yu-Ling Lee, Kun-Yuan Lin, Joy Khag, Ta-Yu Liu et al. · 2026 · Advanced Science
  83. Germline predisposition and somatic mutational landscape in synchronous mucinous metaplasia and neoplasia of the female genital tract
    Ying Yuan, Li Zhang, Jiongbo Liao, Bo Wang, Ling-Hui Lu, Dong-Chen Chu, Yue Shi, Jiaqi Liu, Feng Zhang, Shu-Yan Tang et al. · 2026 · Clinical and Translational Medicine
  84. Targeting ZMYND8 unleashes IL-2 signalling to override T cell exhaustion
    Yan Wang, Hao Shi, Nicole M. Chapman, Anil KC, Renqiang Sun, Hao Song, Xiaoxi Meng, Xiang Sun, Hongbo Chi · 2026 · Nature
  85. Epigenetics in development, disease, and therapy: from mechanisms to clinical interventions
    Yixuan Ren, Lei Yang, Boyi Fei, Rong Guo, Junran Huang, Zhenghao Xu, Ruoran Wang, Pinqi Zhang, Dandan Cao, Pan Chen et al. · 2026 · Science China Life Sciences
  86. Wdr82-COMPASS coordinates Foxp3 and TCR signaling to sustain T reg cell control of microbiota-driven intestinal inflammation
    黄文军, Jun Li, Ming-Hong He, Beisi Xu, Wojciech Rosikiewicz, Xiaolei Hao, Menglin Jiang, Lu Bai, Siwei Zhang, Lei Li et al. · 2026 · Science Advances